These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21281430)
1. Effect of mutant β-catenin on liver growth homeostasis and hepatocarcinogenesis in transgenic mice. Stein TJ; Jochem A; Holmes KE; Sandgren EP Liver Int; 2011 Mar; 31(3):303-12. PubMed ID: 21281430 [TBL] [Abstract][Full Text] [Related]
2. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin. Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813 [TBL] [Abstract][Full Text] [Related]
3. Minimal cooperation between mutant Hras and c-myc or TGFα in the regulation of mouse hepatocyte growth or transformation in vivo. Stein TJ; Bowden M; Sandgren EP Liver Int; 2011 Oct; 31(9):1298-305. PubMed ID: 22093452 [TBL] [Abstract][Full Text] [Related]
4. Mutant Hras(G12V) and Kras(G12D) have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice. Figueiredo ML; Stein TJ; Jochem A; Sandgren EP Liver Int; 2012 Apr; 32(4):582-91. PubMed ID: 22221894 [TBL] [Abstract][Full Text] [Related]
5. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET. Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Tan X; Apte U; Micsenyi A; Kotsagrelos E; Luo JH; Ranganathan S; Monga DK; Bell A; Michalopoulos GK; Monga SP Gastroenterology; 2005 Jul; 129(1):285-302. PubMed ID: 16012954 [TBL] [Abstract][Full Text] [Related]
7. Phenotype of single hepatocytes expressing an activated version of β-catenin in liver of transgenic mice. Schreiber S; Rignall B; Braeuning A; Marx-Stoelting P; Ott T; Buchmann A; Hammad S; Hengstler JG; Schwarz M; Köhle C J Mol Histol; 2011 Oct; 42(5):393-400. PubMed ID: 21822615 [TBL] [Abstract][Full Text] [Related]
8. c-Myc and transforming growth factor α enhance the development of hepatic lesions due to mutant β-catenin in transgenic mice. Jochem AS; Holmes KE; Stein TJ Comp Med; 2014 Oct; 64(5):351-9. PubMed ID: 25402175 [TBL] [Abstract][Full Text] [Related]
9. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Apte U; Zeng G; Muller P; Tan X; Micsenyi A; Cieply B; Dai C; Liu Y; Kaestner KH; Monga SP Hepatology; 2006 Oct; 44(4):992-1002. PubMed ID: 17006939 [TBL] [Abstract][Full Text] [Related]
10. The transcription factor c-Jun protects against liver damage following activated β-Catenin signaling. Trierweiler C; Blum HE; Hasselblatt P PLoS One; 2012; 7(7):e40638. PubMed ID: 22792392 [TBL] [Abstract][Full Text] [Related]
11. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Calvisi DF; Factor VM; Loi R; Thorgeirsson SS Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770 [TBL] [Abstract][Full Text] [Related]
12. Zonation of heme synthesis enzymes in mouse liver and their regulation by β-catenin and Ha-ras. Braeuning A; Schwarz M Biol Chem; 2010 Nov; 391(11):1305-13. PubMed ID: 20707599 [TBL] [Abstract][Full Text] [Related]